跳至主要内容
临床试验/NCT04406116
NCT04406116Unknown不适用

Clinical Evaluation of the Safety and Performance of Microwave Coagulation Using the HS1 Instrument for Actual or Potential Non-variceal Bleeding in the Upper Gastrointestinal (GI) Tract

Creo Medical Limited1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2020年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
35
试验地点
1
主要终点
Effective coagulation of of actual or potential non-variceal bleeding in the upper Gastrointestinal (GI) tract.

研究概览

简要总结

Clinical evaluation of the safety and performance of microwave coagulation using the HS1 Instrument for actual or potential non-variceal bleeding in the upper Gastrointestinal (GI) tract

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient or authorised representative able to comprehend and sign the Informed Consent form.
  • Actual or potential non-variceal bleeding in the upper GI, including angiodysplasia or AVM malformations such as Dieulafoy's lesion with a Glasgow-Blatchford score of greater than 1

排除标准

  • As stated in the contraindications in the HS1 IFU;
  • Aged <18 years of age
  • Those described as vulnerable populations in EN ISO 14155;
  • Patients with a known coagulopathy (congenital);
  • Concurrent participation in another experimental intervention or drug study
  • Unwilling or unable to provide informed consent.
  • A patient whose Glasgow-Blatchford score is 1 or less

结局指标

主要结局

Effective coagulation of of actual or potential non-variceal bleeding in the upper Gastrointestinal (GI) tract.

时间窗: Perioperative

Primary haemostasis at day 0 using microwave coagulation of active bleeding or pre-coagulation of exposed vessels.

次要结局

  • Identification and incidence of intra-procedural complications(Day 0)
  • Identification and incidence of post-procedural complications(At 24-72 hours, 1 week and 4 weeks)
  • Change in Glasgow-Blatchford score(Day 0 for initial screen and then 24-72 hours post-procedure for second score.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验